The current Journal of Clinical Oncology issue features 'Correlative Science in the Cooperative Group System—Re-Engineering ...
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors ...
When it comes to biopharma research and development (R&D) dealmaking, oncology has long been the number-one focus. In the past few years, the headline value of deals in this therapy area has been ...
Copyright: © 2024 Published by Elsevier Ltd. The Lancet Oncology is delighted to announce that we will be entering a collaboration with the European Society for ...
Six and a half years after his diagnosis, Freeberg closed the inaugural Oncology Ventures fund with $30 million in committed capital. It’s a challenging fundraising environment for emerging ...
But a new study from researchers in Denmark may help you avoid the dreaded paper cut – a painful experience for office workers and book readers alike. Thanks to their lab experiments ...
Predictive Oncology’s platform addresses this challenge ... future operations, future financial position, future revenue and financial performance, projected costs, prospects, changes in ...
To explore this situation and analyse potential best practice, QuintilesIMS brought together four of its industry thought leaders to author a new white paper: Oncology Phase 1 Trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback